Latest price-to-book ratio
Compass Therapeutics Price-to-book ratio
Direct answer
Compass Therapeutics's price-to-book ratio is 0.91x.
The verified market snapshot reports 0.91x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Price-to-book ratio
- 0.91x
Explore related company data
View Compass Therapeutics's market capitalizationView Compass Therapeutics's return on equityView Compass Therapeutics's dividend yieldView Compass Therapeutics's 52-week price rangeView Compass Therapeutics's profit marginView Compass Therapeutics's debt-to-equity ratioView all Compass Therapeutics key metricsReturn to Compass Therapeutics profile